Lewes, DE -- (SBWire) -- 10/29/2015 --The Competitive Intelligence report about Interleukin-23 (IL-23) and IL-12/23 antagonists provides a competitor analysis of approved or being developed novel antagonists of interleukin-23 and IL-12/23 (p40 subunit) for treatment of psoriasis and other inflammatory diseases as of September 2015. Purchase of the pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.
The report provides a compilation of active products and projects on the market or in research and development as specific IL-23 or IL-12/23 (p40) antagonists as well as dual target IL-23 antagonists for treatment of immunologic diseases. Competitor projects are listed in a tabular format providing information on:
- Drug Codes
- Target / Mechanism of Action
- Class of Compound
- Company
- Product Category
- Indication,
- R&D Stage and
- additional comments with a hyperlink leading to the source of information.
Spanning over 16 pages "Competitor Analysis: Interleukin-23 & IL-12/23 Antagonists" report covers IL-12/23 (p40) Antagonists, Selective IL-23 Antagonists, Dual Target IL-23 Antagonists, Corporate IL-23 & IL-12/23 R&D Portfolios.
For further information on this report, please visit- http://www.marketresearchreports.com/la-merie-publishing/competitor-analysis-interleukin-23-il-1223-antagonists
Find all Therapeutic Reports at: http://www.marketresearchreports.com/therapeutic
Related Reports:
Competitor Analysis: Sphingosine-1-Phosphate (S1P) Receptor Modulators - visit at: http://www.marketresearchreports.com/la-merie-publishing/competitor-analysis-sphingosine-1-phosphate-s1p-receptor-modulators
Competitor Analysis: Interleukin-4/-13 (IL-4/-13) Inhibitors or Receptor Antagonists - visit at: http://www.marketresearchreports.com/la-merie-publishing/competitor-analysis-interleukin-4-13-il-4-13-inhibitors-or-receptor-antagonists
Competitor Analysis: Amyloid beta- and Tau-Targeted Antibodies & Vaccines - visit at: http://www.marketresearchreports.com/la-merie-publishing/competitor-analysis-amyloid-beta-and-tau-targeted-antibodies-vaccines
About Market Research Reports, Inc.
Market Research Reports, Inc. is the world's leading source for market research reports and market data. We provide you with the latest market research reports on global markets, key industries, leading companies, new products and latest industry analysis & trends.
Yearly/Quarterly Report Subscription: http://www.marketresearchreports.com/subscriptions
Competitor Analysis: Interleukin-23 & IL-12/23 Antagonists, New Report Launched
Market Research Reports, Inc. has announced the addition of “Competitor Analysis: Interleukin-23 & IL-12/23 Antagonists” research report to their website www.MarketResearchReports.com